Published in J R Soc Interface on September 22, 2010
Electrospun nanofibers for regenerative medicine. Adv Healthc Mater (2011) 1.44
Cancer research by means of tissue engineering--is there a rationale? J Cell Mol Med (2013) 0.88
Microporous dermal-like electrospun scaffolds promote accelerated skin regeneration. Tissue Eng Part A (2014) 0.87
Regulating interface science healthcare products: myths and uncertainties. J R Soc Interface (2010) 0.85
Liposomes in tissue engineering and regenerative medicine. J R Soc Interface (2014) 0.82
Translation and commercialization of regenerative medicines. J R Soc Interface (2010) 0.75
Tissue engineering. Science (1993) 19.65
Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell (2004) 16.89
Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med (2008) 10.15
Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science (2004) 6.38
Tissue-engineered lungs for in vivo implantation. Science (2010) 5.90
Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med (2010) 5.59
Mechanical regulation of cell function with geometrically modulated elastomeric substrates. Nat Methods (2010) 4.74
Cell adhesion and motility depend on nanoscale RGD clustering. J Cell Sci (2000) 4.13
Electrospinning: applications in drug delivery and tissue engineering. Biomaterials (2008) 4.12
Cell spreading and focal adhesion dynamics are regulated by spacing of integrin ligands. Biophys J (2007) 3.57
Self-assembly of peptide amphiphiles: from molecules to nanostructures to biomaterials. Biopolymers (2010) 2.86
Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat Med (1999) 2.84
Heparin binding nanostructures to promote growth of blood vessels. Nano Lett (2006) 2.65
The effect of nanofiber alignment on the maturation of engineered meniscus constructs. Biomaterials (2007) 2.11
Three-dimensional extracellular matrix-directed cardioprogenitor differentiation: systematic modulation of a synthetic cell-responsive PEG-hydrogel. Biomaterials (2008) 1.78
Tissue-engineered lung: an in vivo and in vitro comparison of polyglycolic acid and pluronic F-127 hydrogel/somatic lung progenitor cell constructs to support tissue growth. Tissue Eng (2006) 1.74
Cell-based tissue engineering for lung regeneration. Am J Physiol Lung Cell Mol Physiol (2006) 1.63
Self-assembled peptide-based hydrogels as scaffolds for anchorage-dependent cells. Biomaterials (2009) 1.52
Three-dimensional electrospun ECM-based hybrid scaffolds for cardiovascular tissue engineering. Biomaterials (2008) 1.48
The influence of electrospun aligned poly(epsilon-caprolactone)/collagen nanofiber meshes on the formation of self-aligned skeletal muscle myotubes. Biomaterials (2008) 1.47
Cell adhesion strength is controlled by intermolecular spacing of adhesion receptors. Biophys J (2010) 1.37
Simplifying the extracellular matrix for 3-D cell culture and tissue engineering: a pragmatic approach. J Cell Biochem (2007) 1.32
Induction of cancer cell death by self-assembling nanostructures incorporating a cytotoxic peptide. Cancer Res (2010) 1.32
Axonal outgrowth on nano-imprinted patterns. Biomaterials (2005) 1.32
Great expectations: private sector activity in tissue engineering, regenerative medicine, and stem cell therapeutics. Tissue Eng Part A (2008) 1.29
Trends in imprint lithography for biological applications. Trends Biotechnol (2006) 1.27
In vitro analysis of a hepatic device with intrinsic microvascular-based channels. Biomed Microdevices (2008) 1.25
Electrospun polydioxanone-elastin blends: potential for bioresorbable vascular grafts. Biomed Mater (2006) 1.23
Biomimicking extracellular matrix: cell adhesive RGD peptide modified electrospun poly(D,L-lactic-co-glycolic acid) nanofiber mesh. Tissue Eng (2006) 1.22
Intervertebral disc tissue engineering using a novel hyaluronic acid-nanofibrous scaffold (HANFS) amalgam. Tissue Eng Part A (2008) 1.20
Growth factor delivery from self-assembling nanofibers to facilitate islet transplantation. Transplantation (2008) 1.20
Electrospun micro- and nanofiber tubes for functional nervous regeneration in sciatic nerve transections. BMC Biotechnol (2008) 1.18
Amphiphilic peptides and their cross-disciplinary role as building blocks for nanoscience. Chem Soc Rev (2009) 1.14
Nanobiotechnology and cell biology: micro- and nanofabricated surfaces to investigate receptor-mediated signaling. Annu Rev Biophys (2008) 1.14
The effect of gradually graded shear stress on the morphological integrity of a huvec-seeded compliant small-diameter vascular graft. Biomaterials (2006) 1.08
Mechanical responses of a compliant electrospun poly(L-lactide-co-epsilon-caprolactone) small-diameter vascular graft. Biomaterials (2005) 1.06
Tissue engineering via local gene delivery: update and future prospects for enhancing the technology. Adv Drug Deliv Rev (2000) 1.05
Sustained effects of gene-activated matrices after CNS injury. Mol Cell Neurosci (2001) 1.05
Enhanced neovasculature formation in ischemic myocardium following delivery of pleiotrophin plasmid in a biopolymer. Biomaterials (2005) 1.04
Electrospun fibrinogen: feasibility as a tissue engineering scaffold in a rat cell culture model. J Biomed Mater Res A (2007) 1.03
The influence of nanoscale grooved substrates on osteoblast behavior and extracellular matrix deposition. Biomaterials (2010) 1.02
The response of fibroblasts to hexagonal nanotopography fabricated by electron beam lithography. J Biomed Mater Res A (2008) 1.02
Tissue engineering and organ structure: a vascularized approach to liver and lung. Pediatr Res (2008) 0.98
Bone regeneration by modified gene-activated matrix: effectiveness in segmental tibial defects in rats. Tissue Eng (2006) 0.98
Porous chitosan-gelatin scaffold containing plasmid DNA encoding transforming growth factor-beta1 for chondrocytes proliferation. Biomaterials (2005) 0.97
Electrospun nanofibre fibrinogen for urinary tract tissue reconstruction. Biomed Mater (2007) 0.97
Poly-L-lactic acid/hydroxyapatite electrospun nanocomposites induce chondrogenic differentiation of human MSC. Ann Biomed Eng (2009) 0.96
Influence of systematically varied nano-scale topography on cell morphology and adhesion. Cell Commun Adhes (2007) 0.94
Engineering amount of cell-cell contact demonstrates biphasic proliferative regulation through RhoA and the actin cytoskeleton. Exp Cell Res (2008) 0.93
Nanotechnology in the design of soft tissue scaffolds: innovations in structure and function. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2010) 0.92
Whole proteome analysis of osteoprogenitor differentiation induced by disordered nanotopography and mediated by ERK signalling. Biomaterials (2009) 0.91
Growth of outgrowth endothelial cells on aligned PLLA nanofibrous scaffolds. J Mater Sci Mater Med (2009) 0.88
Engineering an artificial alveolar-capillary membrane: a novel continuously perfused model within microchannels. J Pediatr Surg (2010) 0.87
Novel gene-activated matrix with embedded chitosan/plasmid DNA nanoparticles encoding PDGF for periodontal tissue engineering. J Biomed Mater Res A (2009) 0.86
Matrix-mediated gene transfer to brain cortex and dorsal root ganglion neurones by retrograde axonal transport after dorsal column lesion. J Gene Med (2006) 0.82
Preparation of coculture system with three extracellular matrices using capillary force lithography and layer-by-layer deposition. J Biosci Bioeng (2009) 0.81
Dynamic heterodimer-functionalized surfaces for endothelial cell adhesion. Biomaterials (2005) 0.81
Macro-alignment of electrospun fibers for vascular tissue engineering. J Biomed Mater Res B Appl Biomater (2010) 0.79
Controlling cell adhesion on human tissue by soft lithography. Langmuir (2004) 0.78
Microscale technologies for tissue engineering and biology. Proc Natl Acad Sci U S A (2006) 6.66
Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med (2010) 5.59
Regeneration and experimental orthotopic transplantation of a bioengineered kidney. Nat Med (2013) 5.36
Endothelialized microvasculature based on a biodegradable elastomer. Tissue Eng (2005) 2.23
Progress in tissue engineering. Sci Am (2009) 2.08
Endothelialized networks with a vascular geometry in microfabricated poly(dimethyl siloxane). Biomed Microdevices (2004) 1.97
Biocompatibility analysis of poly(glycerol sebacate) as a nerve guide material. Biomaterials (2005) 1.93
Enhanced in vivo function of bioartificial lungs in rats. Ann Thorac Surg (2011) 1.75
Tissue-engineered small intestine improves recovery after massive small bowel resection. Ann Surg (2004) 1.64
Three-Dimensional Microfluidic Tissue-Engineering Scaffolds Using a Flexible Biodegradable Polymer. Adv Mater (2005) 1.49
Microfabrication of three-dimensional engineered scaffolds. Tissue Eng (2007) 1.48
Engineered vascularized bone grafts. Proc Natl Acad Sci U S A (2010) 1.47
Tissue-engineered hybrid tooth and bone. Tissue Eng (2005) 1.46
Hepatic tissue engineering. Transpl Immunol (2004) 1.36
In vivo bone tissue engineering using mesenchymal stem cells on a novel electrospun nanofibrous scaffold. Tissue Eng (2004) 1.34
Hydrogel-beta-TCP scaffolds and stem cells for tissue engineering bone. Bone (2005) 1.20
The tissue-engineered auricle: past, present, and future. Tissue Eng Part B Rev (2011) 1.20
Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratory. J Cell Mol Med (2007) 1.18
Local delivery of basic fibroblast growth factor increases both angiogenesis and engraftment of hepatocytes in tissue-engineered polymer devices. Transplantation (2002) 1.17
Tissue engineering auricular reconstruction: in vitro and in vivo studies. Biomaterials (2004) 1.17
Tissue-engineered large intestine resembles native colon with appropriate in vitro physiology and architecture. Ann Surg (2003) 1.17
Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantation. J Am Coll Cardiol (2003) 1.15
Highly purified müllerian inhibiting substance inhibits human ovarian cancer in vivo. Clin Cancer Res (2002) 1.15
Lung assist device technology with physiologic blood flow developed on a tissue engineered scaffold platform. Lab Chip (2010) 1.13
Reconstruction of mandibular defects with autologous tissue-engineered bone. J Oral Maxillofac Surg (2004) 1.13
Tissue-engineered esophagus: experimental substitution by onlay patch or interposition. J Thorac Cardiovasc Surg (2003) 1.08
The effect of sustained delivery of vascular endothelial growth factor on angiogenesis in tissue-engineered intestine. Biomaterials (2008) 1.07
Diaphragmatic repair through fetal tissue engineering: a comparison between mesenchymal amniocyte- and myoblast-based constructs. J Pediatr Surg (2006) 1.03
Formation of a mandibular condyle in vitro by tissue engineering. J Oral Maxillofac Surg (2003) 1.01
Effect of GLP-2 on mucosal morphology and SGLT1 expression in tissue-engineered neointestine. Am J Physiol Gastrointest Liver Physiol (2003) 1.01
The retention of extracellular matrix proteins and angiogenic and mitogenic cytokines in a decellularized porcine dermis. Biomaterials (2010) 1.00
Bone marrow derived pluripotent cells are pericytes which contribute to vascularization. Stem Cell Rev (2009) 1.00
Engineering ear constructs with a composite scaffold to maintain dimensions. Tissue Eng Part A (2011) 0.99
Tissue engineering and organ structure: a vascularized approach to liver and lung. Pediatr Res (2008) 0.98
Prospects for tooth regeneration. Periodontol 2000 (2006) 0.98
Toward regenerating a human thumb in situ. Tissue Eng Part A (2009) 0.97
Dynamic rotational seeding and cell culture system for vascular tube formation. Tissue Eng (2003) 0.96
Bioengineered teeth from tooth bud cells. Dent Clin North Am (2006) 0.95
Systemic inhibition of tumor growth and angiogenesis by thrombospondin-2 using cell-based antiangiogenic gene therapy. Cancer Res (2002) 0.95
Tissue-engineered small intestine: ontogeny of the immune system. Transplantation (2002) 0.94
Reconstructing mandibular defects using autologous tissue-engineered tooth and bone constructs. J Oral Maxillofac Surg (2009) 0.94
The need for tolerance in pediatric organ transplantation. Pediatrics (2008) 0.92
Effect of implantation site on hepatocytes heterotopically transplanted on biodegradable polymer scaffolds. Tissue Eng (2003) 0.92
Tissue engineered hybrid tooth-bone constructs. Methods (2008) 0.91
State-of-the-art tissue engineering: from tissue engineering to organ building. Surgery (2005) 0.91
Preserved extracellular matrix components and retained biological activity in decellularized porcine mesothelium. Biomaterials (2010) 0.91
Principles of biomimetic vascular network design applied to a tissue-engineered liver scaffold. Tissue Eng Part A (2010) 0.89
Tissue-engineered colon exhibits function in vivo. Surgery (2002) 0.89
In vitro tissue engineering of a cardiac graft using a degradable scaffold with an extracellular matrix-like topography. J Thorac Cardiovasc Surg (2005) 0.88
Tissue-engineered stomach: a preliminary report of a versatile in vivo model with therapeutic potential. J Pediatr Surg (2003) 0.88
Lymphangiogenesis in tissue-engineered small intestine. Transplantation (2004) 0.88
Liver-assist device with a microfluidics-based vascular bed in an animal model. Ann Surg (2010) 0.88
Angiogenesis in tissue-engineered small intestine. Tissue Eng (2003) 0.88
A tissue-engineered stomach as a replacement of the native stomach. Transplantation (2003) 0.88
The generation of functionally differentiated, three-dimensional hepatic tissue from two-dimensional sheets of progenitor small hepatocytes and nonparenchymal cells. Transplantation (2004) 0.87
Fetal tracheal augmentation with cartilage engineered from bone marrow-derived mesenchymal progenitor cells. J Pediatr Surg (2003) 0.87
Cartilage engineering from ovine umbilical cord blood mesenchymal progenitor cells. Stem Cells (2005) 0.86
Nanofabricated collagen-inspired synthetic elastomers for primary rat hepatocyte culture. Tissue Eng Part A (2009) 0.86
Effect of ibuprofen on osteoblast differentiation of porcine bone marrow-derived progenitor cells. J Oral Maxillofac Surg (2009) 0.86
Postnatal myocardial augmentation with skeletal myoblast-based fetal tissue engineering. Surgery (2006) 0.86
Tissue-engineered neomucosa: morphology, enterocyte dynamics, and SGLT1 expression topography. Transplantation (2003) 0.86
The engineering of craniofacial tissues in the laboratory: a review of biomaterials for scaffolds and implant coatings. Dent Clin North Am (2006) 0.85
Hydrogel optimization for cultured elastic chondrocytes seeded onto a polyglycolic acid scaffold. J Biomed Mater Res A (2005) 0.85
An overview of the pathology and approaches to tissue engineering. Ann N Y Acad Sci (2002) 0.85
Successful creation of tissue-engineered autologous auricular cartilage in an immunocompetent large animal model. Tissue Eng Part A (2013) 0.84
Osteoclastogenesis on tissue-engineered bone. Tissue Eng (2004) 0.84
Design of composite scaffolds and three-dimensional shape analysis for tissue-engineered ear. J R Soc Interface (2013) 0.84
Fetal tissue engineering: in utero tracheal augmentation in an ovine model. J Pediatr Surg (2002) 0.84
Comparison of hydrogels in the in vivo formation of tissue-engineered bone using mesenchymal stem cells and beta-tricalcium phosphate. Tissue Eng (2007) 0.83
Toward a new blood vessel. Vasc Med (2002) 0.83
A novel tissue engineering approach using an endothelial progenitor cell-seeded biopolymer to treat intracranial saccular aneurysms. J Neurosurg (2012) 0.82
Pulmonary tissue engineering using dual-compartment polymer scaffolds with integrated vascular tree. Int J Artif Organs (2009) 0.81
Fetal tissue engineering: in vitro analysis of muscle constructs. J Pediatr Surg (2003) 0.80
Development of a biodegradable scaffold with interconnected pores by heat fusion and its application to bone tissue engineering. J Biomed Mater Res A (2008) 0.80
Biologic activity of nerve growth factor slowly released from microspheres. J Reconstr Microsurg (2003) 0.80
The history and current status of tissue engineering: The future of pediatric surgery. J Pediatr Surg (2002) 0.80
In vitro cartilage regeneration from proliferated adult elastic chondrocytes. Ann Plast Surg (2005) 0.80
Three-dimensionally printed polycaprolactone and β-tricalcium phosphate scaffolds for bone tissue engineering: an in vitro study. J Oral Maxillofac Surg (2011) 0.80
Branched vascular network architecture: a new approach to lung assist device technology. J Thorac Cardiovasc Surg (2010) 0.79
Tissue-engineered spleen protects against overwhelming pneumococcal sepsis in a rodent model. J Surg Res (2008) 0.79
Growth factor directed chondrogenic differentiation of porcine bone marrow-derived progenitor cells. J Craniofac Surg (2013) 0.78
Biologic properties of surgical scaffold materials derived from dermal ECM. Biomaterials (2013) 0.78
A novel pulsatile, laminar flow bioreactor for the development of tissue-engineered vascular structures. Tissue Eng (2002) 0.78
Ultra-thin, gas permeable free-standing and composite membranes for microfluidic lung assist devices. Biomaterials (2011) 0.78
Engineered fetal cartilage: structural and functional analysis in vitro. J Pediatr Surg (2002) 0.78
Effect of interferon-alpha-2b on porcine mesenchymal stem cells. J Oral Maxillofac Surg (2006) 0.78
Influence of vascular network design on gas transfer in lung assist device technology. ASAIO J (2011) 0.78
Left ventricular functional recovery with percutaneous, transvascular direct myocardial delivery of bone marrow-derived cells. J Heart Lung Transplant (2005) 0.77
Human shaped thumb bone tissue engineered by hydrogel-beta-tricalciumphosphate/poly-epsilon-caprolactone scaffolds and magnetically sorted stem cells. Ann Plast Surg (2007) 0.77
Mechanical dissociation of swine liver to produce organoid units for tissue engineering and in vitro disease modeling. Artif Organs (2010) 0.76
The promise of artificial liver replacement. Front Biosci (2008) 0.76
Assessing emerging technologies--the case of organ replacement technologies: volume, durability, cost. Int J Technol Assess Health Care (2007) 0.75
Optimizing Biomaterials for Tissue Engineering Human Bone Using Mesenchymal Stem Cells. Plast Reconstr Surg (2016) 0.75
Tissue engineering in the 21st century. Surg Technol Int (2002) 0.75
Poly(glycerol sebacate) films prevent postoperative adhesions and allow laparoscopic placement. Surgery (2009) 0.75
Editorial: tissue engineering: a 20-year personal perspective. Tissue Eng (2007) 0.75
Fetal tissue engineering: chest wall reconstruction. J Pediatr Surg (2003) 0.75
Ovine model for auricular reconstruction: porous polyethylene implants. Ann Otol Rhinol Laryngol (2014) 0.75
Initial assessment of a tissue engineered stomach derived from syngeneic donors in a rat model. ASAIO J (2004) 0.75